Cancer

Research at Harvard Medical school caused intracranial tumor in rodents. Then they injected human neural stem cells. Within days the cell had migrated into the cancerous and produced cytosine deaminase, an enzyme that converts a non-toxic pro-drug into a chemotherapeutic agent. As a result, the injected substance was able to reduce tumor mass by 80%.